Sovaldi Tablet, Film Coated
Product Images NDC 61958-1503

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Sovaldi (NDC 61958-1503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sovaldi 01)

FDA Label Image

Sovaldi 01a

FDA Label Image

Sovaldi 01b

FDA Label Image

Sovaldi 01c

FDA Label Image

Sovaldi 01d

FDA Label Image

Sovaldi 01e

FDA Label Image

Sovaldi 01f

FDA Label Image

Sovaldi 01g

FDA Label Image

Sovaldi 01h

FDA Label Image

Sovaldi 01i

FDA Label Image

Sovaldi 01j

FDA Label Image

Sovaldi 01k

FDA Label Image

Sovaldi 01l

FDA Label Image

Sovaldi 01m

FDA Label Image

Sovaldi 01n

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

This is a description of Sovaldi, a medication manufactured by Gilead Sciences, Inc. Each tablet contains 400 mg of sofosbuvir and is dispensed in its original container with a unique NDC number. The medication is taken once daily according to the dosage and administration instructions included in the package insert. The container carries an "ALERT" box that should not be covered by the pharmacy label. The text does not contain any further information.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Sovaldi® Tablets are a product of Gilead Sciences. The Tablets come in a bottle containing 28 tablets with each tablet containing 400 mg of sofosbuvir. The tablets should be stored below 30 °C (86 °F). The package contains an insert giving dosage and administration advice. The recommended dosage is one tablet per day. These tablets should only be dispensed in their original container. The product is manufactured for Gilead Sciences, Inc. in Canada.*

FDA Label Image

Sovaldi 04

Sovaldi tablets contain 200mg of sofosbuvir each and must be stored below 30 °C (86 °F). Dosage and administration information can be found in the package insert. These tablets are manufactured for Gilead Sciences, Inc. and made in Canada. Each package contains 28 tablets and should only be dispensed in the original container. The recommended dosage is one tablet per day. The ALERT box on the package should not be covered by a pharmacy label. There is some unclear text which may indicate the medicine should not be taken with other drugs, but it is not fully legible.*

FDA Label Image

Sovaldi 05

Sovaldi® is a medication available in the form of oral pellets. Each packet contains 150mg of the medication. There are 28 packets in one container identified by the NDC code 61958-1504-1. The package includes an alert box for informing patients about medicine combinations that should be avoided while taking Sovaldi®.*

FDA Label Image

Sovaldi 06

This is a packaging of Sovaldi® (sofosbuvir) oral pellets with 28 packets, each containing 200 mg. The labeled box also contains a note to pharmacists to not cover the ALERT box with the pharmacy label. The second half of the text appears to be cut off and is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.